Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis

Journal of Rheumatology

Volumn 32, Issue 7, 2005, Pages 1232-1242

  Genovese, Mark C ^a   Bathon, Joan M ^b   Fleischmann, Roy M ^c   Moreland, Larry W ^d   Martin, Richard W ^e   Whitmore, James B ^f   Tsuji, Wayne H ^f   Leff, Jonathan A ^f  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f AMGEN INC   (United States)

Author keywords

Biological response modifiers; Clinical trials; Etanercept; Rheumatoid arthritis; Treatment

Indexed keywords

ETANERCEPT; METHOTREXATE;

ABDOMINAL PAIN; ADULT; AGED; ANGINA PECTORIS; ARTICLE; B CELL LYMPHOMA; BONE RADIOGRAPHY; BREAST CANCER; BRONCHITIS; CEREBROVASCULAR ACCIDENT; CHOLECYSTITIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; COLITIS; COLON CANCER; CORTICOSTEROID THERAPY; DEPRESSION; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FRACTURE; HEART INFARCTION; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LONG TERM CARE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOAMELOBLASTOMA; PNEUMONIA; PRIORITY JOURNAL; PROSTATE CANCER; PYELONEPHRITIS; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNCOPE; THORAX PAIN; THROMBOPHLEBITIS;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; METHOTREXATE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 22244476682     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Arend WPD, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
2. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-93.
3. Klareskog L, van der Heijde DM, de Jager JP, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675-81.
4. Lipsky PE, van der Heijde DM, St. Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
5. Keystone E, Kavanaugh AF, Sharp J, et al. Adalimumab (D2E7), a fully human anti-TNF-α monoclonal antibody, inhibits the progression of structural joint damage in patients with active RA despite concomitant methotrexate therapy [abstract]. Arthritis Rheum 2002;46 Suppl:S205.
6. Genovese MC, Bathon JM, Martin RW, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum 2002;46:1443-50.
7. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729-40.
8. van der Heijde DM, van't Hof MA, van Riel PL, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score 1. Ann Rheum Dis 1990;49:916-20.
9. van Riel PLCM. DAS-Score NL. Available from: http://www.reuma-nijmegen. nl/www.das-score.nl. Accessed March 29, 2005.
10. Sharp JT, Lidsky MD, Coffins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971;14:706-20.
11. van der Heijde DM, van Leeuwen MA, van Riel PL, et al. Biannual radiographic assessments of hands and feet in a three-year prospective follow up of patients with early rheumatoid arthritis. Arthritis Rheum 1992;35:26-34.
12. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-1999), DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2002, based on the November 2001 submission. Bethesda, MD: National Cancer Institute; 2002.
13. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001;45:528-36.
14. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis. The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004;50:1740-51.
15. Kochanek KD, Smith BL, Anderson RN. Deaths: preliminary data for 1999. National Vital Statistics Reports 2001;49:1-48.
16. Singh G, Ramey DR, Rausch PL, Schettler JD. Serious infections in rheumatoid arthritis: relationship to immunosuppressive use [abstract]. Arthritis Rheum 1999;42 Suppl:S242.
17. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287-93.
18. Food and Drug Administration. Arthritis advisory committee meeting briefing document for Enbrel® (etanercept). 2003. Available from: http://www.fda.gov/ohrms/dockets/ac/03/briefing/3930B1_03_A-Amgen-Enbrel.pdf. Accessed March 29, 2005.
19. Hulsmans HMJ, Jacobs JWG, van der Heijde DM, Albada-Kuipers GA, Schenk Y, Bijlsma JWJ. The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum 2000;43:1927-40.
20. Van Aken J, Lard L, le Cessie S, Hazes J, Breedveld F, Huizinga T. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2004;63:274-9.
21. Landewe RBM, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis. Long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.